← Back to Search

Mindfulness and CBT for Preventing Severe Mental Illness in Youth (SWELL Trial)

N/A
Recruiting
Led By Rudolf Uher, MD PhD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
FORBOW (Families Overcoming Risks and Building Opportunities for Well-Being) participant between 9-21 years old
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up annual follow-ups over 3, 5, 7 and 10 years
Awards & highlights

SWELL Trial Summary

This trial will test a new intervention to prevent severe mental illness in young people who are at high risk. The intervention will target early preceding factors to severe mental illness, which are often impairing and distressing to the individual but can be improved with self-management skills and parent training. The goal is to intervene early enough in the young person's life that severe mental illness can be prevented.

Who is the study for?
This trial is for young individuals aged 9-21 who are part of the FORBOW study, showing early signs that may predict severe mental illness, like anxiety or mood swings. It's not for those with a severe mental illness diagnosis or who've had significant therapy recently.Check my eligibility
What is being tested?
The trial tests a new preventive intervention called maCBT aimed at improving self-management skills to prevent the development of severe mental illnesses in high-risk youths by addressing early symptoms.See study design
What are the potential side effects?
Since this is a psychological intervention focusing on cognitive behavioral techniques, there might be no direct physical side effects; however, participants could experience emotional discomfort while discussing personal issues.

SWELL Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a FORBOW participant aged between 9 and 21.

SWELL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~annual follow-ups over 3, 5, 7 and 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and annual follow-ups over 3, 5, 7 and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental disorders
Secondary outcome measures
Affective lability
Affective lability - continuous
Anxiety
+6 more

SWELL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: maCBTExperimental Treatment1 Intervention
Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT). This integrated model focuses on normalisation of the unusual experiences, their re-appraisal, exploring helpfulness of current coping, and developing a repertoire of strategies to decrease the impact of these experiences on the young person's life. The maCBT follows a manual describing obligatory and optional therapeutic elements, proposed list of modules, outline of a therapeutic session, and the integrated cognitive model. The model and techniques are adapted to an age range of 9 to 17 years, with more visual material and child friendly language options for the younger part of the age range (9-12) and more teen-relevant and interpersonal content options for the older part of the age range (13-17). The intervention will be delivered in 8 to 16 one-hour sessions in an individual format. Sessions will be initially weekly, and then spaced out to once every two weeks in the latter stages of the intervention.
Group II: ComparisonActive Control1 Intervention
Naturalistic comparison arm: No intervention offered, no intervention prohibited.

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
258 Previous Clinical Trials
83,494 Total Patients Enrolled
3 Trials studying Schizophrenia
251 Patients Enrolled for Schizophrenia
Nova Scotia Health Research FoundationOTHER_GOV
14 Previous Clinical Trials
33,692 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,207 Total Patients Enrolled
13 Trials studying Schizophrenia
727,212 Patients Enrolled for Schizophrenia

Media Library

maCBT Clinical Trial Eligibility Overview. Trial Name: NCT01980147 — N/A
Schizophrenia Research Study Groups: maCBT, Comparison
Schizophrenia Clinical Trial 2023: maCBT Highlights & Side Effects. Trial Name: NCT01980147 — N/A
maCBT 2023 Treatment Timeline for Medical Study. Trial Name: NCT01980147 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a way for me to be involved in this research project?

"To be included in this medical trial, subjects must have a diagnosis of bipolar disorder and fall between the ages of 9 and 21. The research team is looking to recruit 360 participants."

Answered by AI

Does this trial restrict participation to individuals of a certain age range?

"This clinical trial is exclusively for those aged 9 to 21. As such, there are 91 trials specifically targeting minors and 449 studies recruiting adults over the age of 65."

Answered by AI

Are participants currently being sought for this experiment?

"Affirmative. According to the details on clinicaltrials.gov, this medical trial was initially announced on March 22nd 2014 and has recently been updated on February 6th 2023 with 360 participants sought from one site only."

Answered by AI

What is the participant enrollment size for this experiment?

"Affirmative. Information posted on clinicaltrials.gov indicates that this medical research is actively seeking participants, with 360 individuals being targeted across one site since it was first published in March 2014 and last modified in February 2023."

Answered by AI
~6 spots leftby Jun 2024